ArticleJournal of clinical medicine2025

Effectiveness of Ocrelizumab on Disease Progression and Disability Status in Multiple Sclerosis Patients: A Two-Year Prospective Cohort Study.

Amanda Claudia Schuldesz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.